Nike ACG returns to END. for AW18 - check out the lookbook for the latest collection now
EDGE NikeLab ACG Gore-Tex 2 in 1 System Jacket ΛCRИM P23TS-CH | C.E X Ashram Glove #2 NikeLab X Undercover Gyakusou Gaiter Nike Free Huarache Carnivore SP
The techwear magazine commemorates Hugh's work for the function-focused label.
For something I assumed to be ultra-niche at this point in the 21st century, the ACG-themed post from here late last year proved pretty popular in terms of feedback. There’s evidently more Al…
An abstract is unavailable.
The technology can provide assistance to pharmaceutical and nutraceutical companies to remotely monitor production machine settings, performance parameters, machine downtimes, and alarms in real time over the smart connected dashboard.
An abstract is unavailable.
Volanesorsen is a new second-generation antisense oligonucleotide. It lowers triglyceride levels and Apolipoprotein C3 via a mechanism different from
in relieving IBS-C-related abdominal symptoms (bloating, discomfort, and pain) using a novel multi-item Abdominal Score (AS). METHODS: Patients with IBS-C with abdominal pain ≥3 (0–10 scale) were randomized to linaclotide 290 μg or placebo daily for 12 weeks. The AS, derived from the Diary for IBS Symptoms-Constipation, is the average of abdominal bloating, discomfort, and pain at their worst (0 = none, 10 = worst possible). The primary end point was overall change from baseline (CFB) in AS. Secondary end points included CFB in 12-week AS evaluated using cumulative distribution function and 6-week/12-week AS responder (AS improvement ≥2 points for ≥6-week/12-week). RESULTS: Overall, 614 patients (mean age 46.7 years; 81% female) were randomized. All prespecified end points showed significant benefit of linaclotide vs placebo. The mean overall CFB AS reduction for linaclotide was −1.9 vs −1.2 for placebo (P < 0.0001); the 6-week/12-week AS responder rate was 40.5% for linaclotide vs 23.4% for placebo (odds ratio = 2.2 [95% confidence interval, 1.55–3.12; P < 0.0001]). Diarrhea was the most common treatment-emergent adverse event (linaclotide = 4.6%, placebo = 1.6%). DISCUSSION: Linaclotide significantly reduced multiple abdominal symptoms important to patients with IBS-C (bloating, discomfort, and pain) compared with placebo, as measured by a novel multi-item AS. The AS, derived from the Diary for IBS Symptoms-Constipation, should be considered for use in future IBS-C clinical studies to measure clinically meaningful improvements beyond traditional end points....
The spacious, particularly warm ACG "Tuff Fleece" crew neck shirt ensures warm wearing comfort in cold conditions. It's ideal for layering and the fitted, ribbed openings seal in warmth. Our Therma-FIT technology regulates your body temperature, helping you stay toasty at base camp or in your backyard by the fire pit while counting the stars with your friends. Nike Therma-FIT technology harnesses your natural body heat to keep you warm in cold weather. The low shoulders and the spacious design on the chest and body allow for easy combinations and casual wearing comfort. Thick, elastic, ribbed openings prevent the crew neck shirt from slipping when you move and retain your body's natural warmth. More details Embroidered ACG logo on left chest Embroidered Therma-FIT branding on the right sleeve Swoosh logo at back right hem Body: 75% cotton/25% polyester; Rib material: 98% cotton/2% elastane; Machine wash Imported 75% COTTON 25% POLYESTER
“ユウカ普通にお嫁さんにしたいぐらい好き”
Nike's ISPA collection has new clothes & sneakers dropping for Fall 2023, including some impressively technical new jackets & shirts.
アオいいよね
At ACG Yoobee School of Design, our Graphic Design courses give you all the skills you need to translate your creativity from the page to the screen. Our Graphic…
